The novel selective PPARα modulator (SPPARMα) pemafibrate improves dyslipidemia, enhances reverse cholesterol transport and decreases inflammation and atherosclerosis

Overview of attention for article published in Atherosclerosis (00219150), March 2016

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (75th percentile)
Good Attention Score compared to outputs of the same age and source (79th percentile)

So far, Altmetric has seen 1 X post from an account with 398 followers.

Pemafibrate exerts beneficial effects on lipid metabolism, and inflammation resulting in anti-atherogenic properties https://t.co/5BUgpA2TuA

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.